Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney*
暂无分享,去创建一个
H. Abboud | K. Block | Y. Gorin | J. Barnes | James Hernandez | B. Bhandari | B. Wagner | James D. Hernandez
[1] M. Dinauer,et al. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. , 2006, Cellular signalling.
[2] L. Yao,et al. Role of NAD(P)H Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Cardioprotection of Ischemic Reperfusion Injury by Angiotensin II , 2005, Hypertension.
[3] P. Iyengar,et al. The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.
[4] W. Couser,et al. Mechanical stretch induces podocyte hypertrophy in vitro. , 2005, Kidney international.
[5] M. Geiszt,et al. The Nox Family of NAD(P)H Oxidases: Host Defense and Beyond* , 2004, Journal of Biological Chemistry.
[6] J. Keaney,et al. Mitochondrial Function Is Required for Hydrogen Peroxide-induced Growth Factor Receptor Transactivation and Downstream Signaling* , 2004, Journal of Biological Chemistry.
[7] H. Abboud,et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. , 2004, The Biochemical journal.
[8] M. Kuo,et al. Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells. , 2004, Molecular pharmacology.
[9] A. Segal,et al. The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems. , 2004, Biochimica et biophysica acta.
[10] G. Wolf,et al. Angiotensin II and Cell Cycle Regulation , 2004, Hypertension.
[11] F. DeRubertis,et al. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. , 2004, Diabetes.
[12] M. Brand,et al. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. , 2004, Diabetes.
[13] H. Abboud,et al. Tyrosine phosphorylation-dependent PI 3 kinase/Akt signal transduction regulates TGFbeta-induced fibronectin expression in mesangial cells. , 2004, Cellular signalling.
[14] G. Wolf. Growth factors and the development of diabetic nephropathy , 2003, Current diabetes reports.
[15] A. Phillips. The role of renal proximal tubular cells in diabetic nephropathy , 2003, Current diabetes reports.
[16] S. Araki,et al. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. , 2003, Diabetes.
[17] E. Araki,et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. , 2003, Diabetes.
[18] H. Nawata,et al. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment , 2003, Diabetologia.
[19] I. G. Fantus,et al. High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells* , 2003, Journal of Biological Chemistry.
[20] H. Utsumi,et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. , 2003, Journal of the American Society of Nephrology : JASN.
[21] A. Shah,et al. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[22] R. Carey,et al. The intrarenal renin–angiotensin system and diabetic nephropathy , 2003, Trends in Endocrinology & Metabolism.
[23] M. Haneda,et al. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. , 2003, Journal of the American Society of Nephrology : JASN.
[24] G. King,et al. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. , 2003, Journal of the American Society of Nephrology : JASN.
[25] H. Ha,et al. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[26] T. Patel,et al. Transforming growth factor-inhibition of proteasomal activity : a potential mechanism of growth arrest , 2003 .
[27] T. Noll,et al. Role of Redox Signaling in the Autonomous Proliferative Response of Endothelial Cells to Hypoxia , 2003, Circulation research.
[28] M. Haneda,et al. Overview of glucose signaling in mesangial cells in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[29] C. Kim,et al. Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia. , 2003, Diabetes research and clinical practice.
[30] F. Martin,et al. The Role of p42/44 MAPK and Protein Kinase B in Connective Tissue Growth Factor Induced Extracellular Matrix Protein Production, Cell Migration, and Actin Cytoskeletal Rearrangement in Human Mesangial Cells* , 2002, The Journal of Biological Chemistry.
[31] Merlin C. Thomas,et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. , 2002, Diabetes.
[32] C. Schnackenberg. Oxygen radicals in cardiovascular-renal disease. , 2002, Current opinion in pharmacology.
[33] Maristela L Onozato,et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. , 2002, Kidney international.
[34] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[35] H. Abboud,et al. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox‐dependent pathway and independent of phosphoinositide 3‐kinase , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] M. Brownlee,et al. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. , 2001, Diabetes.
[37] T. Münzel,et al. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.
[38] M. Hattori,et al. A Novel Superoxide-producing NAD(P)H Oxidase in Kidney* , 2001, The Journal of Biological Chemistry.
[39] R. Kitsis,et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.
[40] S. Hong,et al. Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. , 2000, Journal of the American Society of Nephrology : JASN.
[41] C. Obejero-Paz,et al. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. , 2000, The Journal of clinical investigation.
[42] K. Sharma,et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[43] P. Várnai,et al. Identification of renox, an NAD(P)H oxidase in kidney. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[45] S. Shin,et al. Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. , 2000, The Journal of laboratory and clinical medicine.
[46] G. Wolf,et al. Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.
[47] Y. Hinokio,et al. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications , 1999, Diabetologia.
[48] H. Utsumi,et al. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes , 1998, Diabetologia.
[49] J. Douglas,et al. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Meloche,et al. Inhibition of Growth Factor-induced Protein Synthesis by a Selective MEK Inhibitor in Aortic Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.
[51] P. Klotman,et al. Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. , 1995, Kidney international.
[52] J. Hancock,et al. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. , 1995, Journal of the American Society of Nephrology : JASN.
[53] K. H. Kim,et al. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. , 1994, Free radical biology & medicine.
[54] F. Ziyadeh. The extracellular matrix in diabetic nephropathy. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[55] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[56] R. Bilous,et al. Mean Glomerular Volume and Rate of Development of Diabetic Nephropathy , 1989, Diabetes.
[57] J. Velosa,et al. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin. , 1982, The Journal of clinical investigation.